• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

总分析误差和测量不确定度在分析性能评估和葡萄糖危急值限的灰色区域确定中的应用。

Total Analytical Error and Measurement Uncertainty for Analytical Performance Evaluation and Determination of Gray Zones of Glucose Critical Value Limits.

机构信息

Consultant on Biochemistry, Eskişehir, Turkey.

出版信息

Lab Med. 2023 Mar 7;54(2):153-159. doi: 10.1093/labmed/lmac077.

DOI:10.1093/labmed/lmac077
PMID:36053235
Abstract

OBJECTIVE

Total analytical error (TAE) and measurement uncertainty (MU) are important approaches to evaluating and improving the quality of measurement procedures. This study evaluates glucose analytical performance (AP) according to TAE and MU and calculates gray zones of glucose critical value limits.

METHODS

Using TAE and MU values, AP was evaluated according to 5 different analytical performance specifications (APS) and the gray zones of critical value limits were calculated. The number of patients in these zones was compared.

RESULTS

TAE was higher than MU at all 3 levels. The AP for the low glucose level was poor. The number of patients in the gray zones was statistically higher in the TAE groups than in the MU groups (P < .05).

CONCLUSION

TAE and MU values can be used to evaluate the AP of glucose measurement as well as to evaluate the compliance of patient results with decision limits by creating gray zones.

摘要

目的

总分析误差(TAE)和测量不确定度(MU)是评估和提高测量程序质量的重要方法。本研究根据 TAE 和 MU 评估葡萄糖分析性能(AP),并计算葡萄糖临界值限的灰色区域。

方法

使用 TAE 和 MU 值,根据 5 种不同的分析性能规格(APS)评估 AP,并计算临界值限的灰色区域。比较这些区域内的患者数量。

结果

在所有 3 个水平上,TAE 均高于 MU。低血糖水平的 AP 较差。TAE 组的灰色区域内的患者数量明显高于 MU 组(P<0.05)。

结论

TAE 和 MU 值可用于评估葡萄糖测量的 AP,通过创建灰色区域,还可以评估患者结果与决策限的符合程度。

相似文献

1
Total Analytical Error and Measurement Uncertainty for Analytical Performance Evaluation and Determination of Gray Zones of Glucose Critical Value Limits.总分析误差和测量不确定度在分析性能评估和葡萄糖危急值限的灰色区域确定中的应用。
Lab Med. 2023 Mar 7;54(2):153-159. doi: 10.1093/labmed/lmac077.
2
Evaluation of 20 clinical chemistry and 12 immunoassay analytes in terms of total analytical error and measurement uncertainty.评估 20 项临床化学和 12 项免疫分析物的总分析误差和测量不确定度。
Scand J Clin Lab Invest. 2021 Nov;81(7):517-522. doi: 10.1080/00365513.2021.1955294. Epub 2021 Jul 27.
3
APS calculator: a data-driven tool for setting outcome-based analytical performance specifications for measurement uncertainty using specific clinical requirements and population data.APS 计算器:一款数据驱动的工具,用于根据特定的临床要求和人群数据,为测量不确定度制定基于结果的分析性能规格。
Clin Chem Lab Med. 2023 Nov 17;62(4):597-607. doi: 10.1515/cclm-2023-0740. Print 2024 Mar 25.
4
Measuring Analytical Quality: Total Analytical Error Versus Measurement Uncertainty.测量分析质量:总分析误差与测量不确定度
Clin Lab Med. 2017 Mar;37(1):1-13. doi: 10.1016/j.cll.2016.09.001. Epub 2016 Dec 20.
5
Useful measures and models for analytical quality management in medical laboratories.医学实验室分析质量管理的有用措施和模型。
Clin Chem Lab Med. 2016 Feb;54(2):223-33. doi: 10.1515/cclm-2015-0710.
6
Comparison of Two Clinical Chemistry Analyzers by Total Analytical Error and Measurement Uncertainty.通过总分析误差和测量不确定度对两种临床化学分析仪进行比较
Clin Lab. 2023 Jan 1;69(1). doi: 10.7754/Clin.Lab.2022.220846.
7
What information on measurement uncertainty should be communicated to clinicians, and how?关于测量不确定度的哪些信息应传达给临床医生,以及如何传达?
Clin Biochem. 2018 Jul;57:18-22. doi: 10.1016/j.clinbiochem.2018.01.017. Epub 2018 Feb 2.
8
Performance specifications for measurement uncertainty of common biochemical measurands according to Milan models.根据米兰模型的常见生化测量物测量不确定度的性能规范。
Clin Chem Lab Med. 2021 Mar 16. doi: 10.1515/cclm-2021-0170.
9
Implementation of metrological traceability in laboratory medicine: where we are and what is missing.计量溯源性在检验医学中的实施:我们的现状与不足。
Clin Chem Lab Med. 2020 Jul 28;58(8):1200-1204. doi: 10.1515/cclm-2019-1128.
10
Evaluation of Measurement Uncertainties of Immunoassays Analytes According to Biological Variation Databases.根据生物学变异数据库评估免疫分析物测量不确定度。
Clin Lab. 2022 Sep 1;68(9). doi: 10.7754/Clin.Lab.2021.210906.

引用本文的文献

1
Are Your Laboratory Data Reproducible? The Critical Role of Imprecision from Replicate Measurements to Clinical Decision-making.你的实验室数据可重复吗?从重复测量的不精密度到临床决策的关键作用。
Ann Lab Med. 2025 May 1;45(3):259-271. doi: 10.3343/alm.2024.0569. Epub 2025 Mar 21.
2
Development and evaluation of a whole-chain management system for critical value reporting.危急值报告全链管理系统的开发与评估
BMC Med Inform Decis Mak. 2025 Feb 27;25(1):104. doi: 10.1186/s12911-025-02936-6.